🟢 Precigen is trading 5% up today after B. Riley initiated Buy coverage

Precigen is trading at $8.08, up 4.94% on September 25, 2026, after B. Riley initiated coverage with a Buy rating and a $12 price target.

• The target implies approximately 56% upside from the prior close of $7.70.
• B. Riley highlighted the commercial-stage Papzimeos opportunity.
• Broader indices are modestly higher, but the move appears primarily company-driven.